ISSN: 0885-6222

Journal Home

Journal Guideline

Human Psychopharmacology Q3 Unclaimed

John Wiley and Sons Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human Psychopharmacology is a journal indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 86. It has a price of 2040 €. It has an SJR impact factor of 0,541 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,541.

Human Psychopharmacology focuses its scope in these topics and keywords: efficacy, biloba, antidepressants, disorder, trials, review, healthy, effects, openlabel, clinical, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Neurology (Q3) Neurology (clinical) (Q3) Neurology (clinical) (Q3) Pharmacology (medical) (Q3) Psychiatry and Mental Health (Q3)

Price

2040 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,541

SJR Impact factor

86

H Index

23

Total Docs (Last Year)

117

Total Docs (3 years)

1225

Total Refs

246

Total Cites (3 years)

116

Citable Docs (3 years)

1.98

Cites/Doc (2 years)

53.26

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CNS oncology Q3
Neurology: Clinical Practice Q3
Restorative Neurology and Neuroscience Q3
Translational Medicine of Aging Q3
Stroke Research and Treatment Q3

Compare this journals

Aims and Scope

Best articles by citations

Low doses of alcohol have a selective effect on the recognition of happy facial expressions

Psychiatry as a neuroscience. edited by J. J. Lopez-Ibor, W. Gaebel, M. Maj and N. Sartorius. John Wiley and Sons: Chichester, UK, 2002. ISBN 0-471-49656-1. Price ¬£60.00. Pages 330.

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge

Nizatidine for the treatment of patients with quetiapine-induced weight gain

The effect of nabilone on neuropsychological functions related to driving ability: an extended case series

Acute glucocorticoid effects on the multicomponent model of working memory

Effects ofGinkgo biloba on alertness and chemosensory function in healthy adults

Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice

The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale(MADRS) using a structured interview guide for MADRS(SIGMA)

Comments on the paper ?The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study?

Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications

The acute effects ofL-theanine in comparison with alprazolam on anticipatory anxiety in humans

SHOW MORE ARTICLES

Repetitive transcranial magnetic stimulation is effective following repeated courses in the treatment of major depressive disorder?a case report

Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients

Use of drugs in psychiatry: the evidence from psychopharmacology. (Fifth edition). Edited by John Cookson, Cornelius Katona and David Taylor. Royal College of Psychiatrists. Cromwell Press Ltd: Trowbridge, 2002. Pages: 416. ISBN 1-901242-29-3. ¬£20.0

Schizotypy, marijuana, and differential item functioning

Effects of smoking marijuana on focal attention and brain blood flow

Effects of smoking on diurnal variations of subjective activation and mood

Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users

Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement

Milnacipran plasma levels and antidepressant response in Japanese major depressive patients

A preliminary study of baclofen-induced growth hormone release in generalised social phobia

Acute cholecystokinin effects on event-related potentials in healthy volunteers